Response by van Doorn et al to Letters Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”
DSpace/Manakin Repository
Response by van Doorn et al to Letters Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”
van Doorn, Sander; Rutten, Frans H.; Geersing, Geert Jan
(2024) Circulation, volume 150, issue 2, pp. e30 - e32
(Comment)
Download/Full Text
The full text of this publication is not available.